Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R01)
Deadline: Standard NIH Deadlines
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project
The lack of appropriate pediatric formulations has been identified as a major obstacle for the study and use of drugs in children. Pediatric formulations may be inappropriate for different reasons. Children under 12 years of age often have difficulty in swallowing capsules, while those under 4 years generally cannot swallow tablets. This Funding Opportunity Announcement (FOA) encourages grant applications to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. Development and testing of novel pediatric drug delivery systems is also part of this initiative.
- Clinical trials not allowed
- Companion funding